文献速递主动脉疾病

多数私人保险患者未接受联邦推荐的腹主动脉瘤筛查

Most privately insured patients do not receive federally recommended abdominal aortic aneurysm screening.
PubMed 文献 · J Vasc Surg · 2023-02-11

该研究基于IBM Marketscan商业及Medicare补充数据库(2006-2017年),纳入65至75岁连续参保的男性既往吸烟者,评估美国预防服务工作组推荐的腹主动脉瘤超声筛查依从性。在35154例合格患者中,13612例(38.7%)接受了筛查,依从性因州而异,从明尼苏达州的24.4%到蒙大拿州的51.6%(P < .05)。筛查活动逐年增加,2008年占0.7%,2016年占22.2%(P < .05)。

要点

  • 在35154例合格患者中,仅38.7%接受了推荐的腹主动脉瘤筛查。
  • 筛查依从性因州而异,范围从24.4%到51.6%(P < .05)。
  • 居住在大都市统计区外与筛查呈负相关(OR 0.92;95% CI 0.87-0.97)。

研究设计与样本

  • 查询IBM Marketscan商业及Medicare补充数据库(2006-2017年),纳入65至75岁连续参保的男性既往吸烟者,排除既往腹主动脉瘤、结缔组织病、主动脉手术史以及65至75岁期间接受腹部CT或MRI的患者,筛查定义为完整的腹部、腹膜后或主动脉超声。

主要发现

  • 在35154例合格患者中,13612例(38.7%)接受了筛查。
  • 筛查依从性因州而异,从明尼苏达州的24.4%到蒙大拿州的51.6%(P < .05)。
  • 筛查活动逐年增加,2008年0.7%的筛查活动 vs 2016年22.2%(P < .05)。
  • 在调整州作为随机截距的logistic混合效应模型中,高血压史(OR 1.07;95% CI 1.03-1.13)、冠心病(OR 1.17;95% CI 1.10-1.22)、充血性心力衰竭(OR 1.14;95% CI 1.01-1.22)、糖尿病(OR 1.1;95% CI 1.06-1.16)和慢性肾脏病(OR 1.4;95% CI 1.24-1.53)与筛查相关。
  • 居住在大都市统计区外与筛查呈负相关(OR 0.92;95% CI 0.87-0.97)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Since 2005, the United States Preventative Services Task Force has recommended abdominal aortic aneurysm (AAA) ultrasound screening for 65- to 75-year-old male ever-smokers. Integrated health systems such as Kaiser Permanente and the Veterans Affairs (VA) health care system report 74% to 79% adherence, but compliance rates in the private sector are unknown. METHODS: The IBM Marketscan Commercial and Medicare Supplemental databases (2006-2017) were queried for male ever-smokers continuously enrolled from age 65 to 75 years. Exclusion criteria were previous history of AAA, connective tissue disorder, and aortic surgery. Patients with abdominal computed tomographic or magnetic resonance imaging from ages 65 to 75 years were also excluded. Screening was defined as a complete abdominal, retroperitoneal, or aortic ultrasound. A logistic mixed-effects model utilizing state as a random intercept was used to identify patient characteristics associated with screening. RESULTS: Of 35,154 eligible patients, 13,612 (38.7%) underwent screening. Compliance varied by state, ranging from 24.4% in Minnesota to 51.6% in Montana (P < .05). Screening activity increased yearly, with 0.7% of screening activity occurring in 2008 vs 22.2% in 2016 (P <.05). In a logistic mixed-effects model adjusting for state as a random intercept, history of hypertension (odds ratio [OR], 1.07; 95% confidence interval [CI], 1.03-1.13), coronary artery disease (OR, 1.17; 95% CI, 1.10-1.22), congestive heart failure (OR, 1.14; 95% CI, 1.01-1.22), diabetes (OR, 1.1; 95% CI, 1.06-1.16), and chronic kidney disease (OR, 1.4; 95% CI, 1.24-1.53) were associated with screening. Living outside of a census-designated metropolitan area was negatively associated with screening (OR, 0.92; 95% CI, 0.87-0.97). CONCLUSIONS: In a private claims database representing 250 million claimants, 38.7% of eligible patients received United States Preventative Services Task Force-recommended AAA screening. Compliance was nearly one-half that of integrated health systems and was significantly lower for patients living outside of metropolitan areas. Efforts to improve early detection of AAA should include targeting non-metropolitan areas and modifying Medicare reimbursement and incentivization strategies to improve guideline adherence.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ho VT, Tran K, George EL, et al. Most privately insured patients do not receive federally recommended abdominal aortic aneurysm screening. J Vasc Surg. 2023. PMID: 36781115. doi:10.1016/j.jvs.2023.01.202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。